Nova Leap Health Stock Performance
| NVLPF Stock | USD 0.18 0.00 0.00% |
Nova Leap has a performance score of 3 on a scale of 0 to 100. The company secures a Beta (Market Risk) of -1.21, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Nova Leap are expected to decrease by larger amounts. On the other hand, during market turmoil, Nova Leap is expected to outperform it. Nova Leap Health right now secures a risk of 4.15%. Please verify Nova Leap Health variance, as well as the relationship between the value at risk and rate of daily change , to decide if Nova Leap Health will be following its current price movements.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Nova Leap Health are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Nova Leap may actually be approaching a critical reversion point that can send shares even higher in April 2025. ...more
| Begin Period Cash Flow | 2.8 M | |
| Total Cashflows From Investing Activities | -7.4 M |
Nova |
Nova Leap Relative Risk vs. Return Landscape
If you would invest 17.00 in Nova Leap Health on December 17, 2024 and sell it today you would earn a total of 1.00 from holding Nova Leap Health or generate 5.88% return on investment over 90 days. Nova Leap Health is currently producing 0.1755% returns and takes up 4.1451% volatility of returns over 90 trading days. Put another way, 36% of traded otc stocks are less volatile than Nova, and 97% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Nova Leap Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nova Leap's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Nova Leap Health, and traders can use it to determine the average amount a Nova Leap's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0423
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NVLPF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.15 actual daily | 37 63% of assets are more volatile |
Expected Return
| 0.18 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Nova Leap is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nova Leap by adding it to a well-diversified portfolio.
Nova Leap Fundamentals Growth
Nova OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Nova Leap, and Nova Leap fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nova OTC Stock performance.
| Return On Equity | -0.0309 | |||
| Return On Asset | -0.0294 | |||
| Profit Margin | (0.02) % | |||
| Operating Margin | (0.04) % | |||
| Current Valuation | 18.18 M | |||
| Shares Outstanding | 86.21 M | |||
| Price To Earning | 10.57 X | |||
| Price To Book | 1.12 X | |||
| Price To Sales | 0.79 X | |||
| Revenue | 21.28 M | |||
| EBITDA | 3.74 M | |||
| Cash And Equivalents | 794.12 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 896.13 K | |||
| Debt To Equity | 0.33 % | |||
| Book Value Per Share | 0.22 X | |||
| Cash Flow From Operations | 2.18 M | |||
| Total Asset | 26.77 M | |||
About Nova Leap Performance
By analyzing Nova Leap's fundamental ratios, stakeholders can gain valuable insights into Nova Leap's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Nova Leap has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Nova Leap has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Nova Leap Health Corp. provides home and home health care services in the United States and Canada. Nova Leap Health Corp. was incorporated in 2015 and is headquartered in Halifax, Canada. Nova Leap is traded on OTC Exchange in the United States.Things to note about Nova Leap Health performance evaluation
Checking the ongoing alerts about Nova Leap for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Nova Leap Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nova Leap Health has some characteristics of a very speculative penny stock | |
| Nova Leap Health had very high historical volatility over the last 90 days | |
| Nova Leap Health has accumulated 896.13 K in total debt with debt to equity ratio (D/E) of 0.33, which is about average as compared to similar companies. Nova Leap Health has a current ratio of 0.85, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Nova Leap until it has trouble settling it off, either with new capital or with free cash flow. So, Nova Leap's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nova Leap Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nova to invest in growth at high rates of return. When we think about Nova Leap's use of debt, we should always consider it together with cash and equity. | |
| About 36.0% of Nova Leap outstanding shares are owned by corporate insiders |
- Analyzing Nova Leap's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nova Leap's stock is overvalued or undervalued compared to its peers.
- Examining Nova Leap's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nova Leap's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nova Leap's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Nova Leap's otc stock. These opinions can provide insight into Nova Leap's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Nova OTC Stock analysis
When running Nova Leap's price analysis, check to measure Nova Leap's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Leap is operating at the current time. Most of Nova Leap's value examination focuses on studying past and present price action to predict the probability of Nova Leap's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Leap's price. Additionally, you may evaluate how the addition of Nova Leap to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |